Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma
ConclusionGI-irAEs are associated with improved OS and PFS in patients with metastatic melanoma. Furthermore, higher grades of diarrhea are associated with even better patients ’ OS rates.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Immunotherapy | Melanoma | Skin Cancer | Study